Welcure Drugs & Pharmaceuticals Limited

Equities

WELCURE6

INE331C01017

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:54 2024-06-12 EDT			5-day change	1st Jan Change
5.73 ^INR	+4.95%		+27.05%	+48.83%

06-10	Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Branch Office of the Company	CI
06-10	Welcure Drugs & Pharmaceuticals Limited announced that it expects to receive INR 247.5 million in funding	CI

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Welcure Drugs & Pharmaceuticals Limited

Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Branch Office of the Company	06-10	CI
Welcure Drugs & Pharmaceuticals Limited announced that it expects to receive INR 247.5 million in funding	06-09	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	06-04	CI
Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	03-22	CI
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	02-15	MT
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations	02-15	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer	02-15	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director	02-15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes	02-15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director	02-15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer	02-15	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office	02-14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14	CI
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address	11-14	CI
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes	11-14	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director	23-10-30	CI
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes	23-09-30	CI
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi	23-09-04	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-07-11	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Director Resignations, with Effect from October 8, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Sudhir Chandra as Managing Director, with Effect from October 8, 2022	22-10-08	CI

Chart Welcure Drugs & Pharmaceuticals Limited

Duration

Period

Chart Welcure Drugs & Pharmaceuticals Limited

More charts

Company Profile

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in providing services for procurements of order.

Sector

Pharmaceuticals

Calendar

2024-07-07 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
WELCURE DRUGS & PHARMACEUTICALS LIMITED	+48.83%	882K
MCKESSON CORPORATION	+26.31%	76.86B
CARDINAL HEALTH, INC.	-1.79%	24.12B
SINOPHARM GROUP CO. LTD.	+7.82%	8.71B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+11.36%	8.57B
HUADONG MEDICINE CO., LTD	-23.95%	7.67B
H. LUNDBECK A/S	+15.02%	5.25B
GALENICA AG	+1.51%	4.12B
EBOS GROUP LIMITED	-8.25%	3.88B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+17.02%	3.55B

Pharmaceuticals Wholesale